Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NAUT NASDAQ:ODYS NASDAQ:QSI NASDAQ:SENS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNAUTNautilus Biotechnology$1.89$2.36$0.62▼$4.31$240.18M0.81.17 million shs1.70 million shsODYSOdysight.ai$4.46$4.36$2.60▼$11.30$74.97M-0.5228,736 shs29,591 shsQSIQuantum-Si$0.88$0.98$0.69▼$3.10$192.22M3.25.04 million shs2.90 million shsSENSSenseonics Holdings, Inc. Common Stock$5.38$6.14$4.79▼$12.58$224.90M0.99840,677 shs367,429 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNAUTNautilus Biotechnology0.00%+9.25%-15.63%-36.36%+141.84%ODYSOdysight.ai0.00%+11.22%+21.53%-25.42%-7.08%QSIQuantum-Si0.00%-5.13%-6.76%+11.92%-48.98%SENSSenseonics Holdings, Inc. Common Stock0.00%-1.82%-25.07%-19.94%+537,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNAUTNautilus Biotechnology$1.89$2.36$0.62▼$4.31$240.18M0.81.17 million shs1.70 million shsODYSOdysight.ai$4.46$4.36$2.60▼$11.30$74.97M-0.5228,736 shs29,591 shsQSIQuantum-Si$0.88$0.98$0.69▼$3.10$192.22M3.25.04 million shs2.90 million shsSENSSenseonics Holdings, Inc. Common Stock$5.38$6.14$4.79▼$12.58$224.90M0.99840,677 shs367,429 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNAUTNautilus Biotechnology0.00%+9.25%-15.63%-36.36%+141.84%ODYSOdysight.ai0.00%+11.22%+21.53%-25.42%-7.08%QSIQuantum-Si0.00%-5.13%-6.76%+11.92%-48.98%SENSSenseonics Holdings, Inc. Common Stock0.00%-1.82%-25.07%-19.94%+537,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNAUTNautilus Biotechnology 2.00Hold$4.00111.64% UpsideODYSOdysight.ai 2.33Hold$10.00124.22% UpsideQSIQuantum-Si 1.50Reduce$1.0013.29% UpsideSENSSenseonics Holdings, Inc. Common Stock 2.67Moderate Buy$17.00215.99% UpsideCurrent Analyst Ratings BreakdownLatest ODYS, NAUT, SENS, and QSI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/8/2026QSIQuantum-Si Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/24/2026QSIQuantum-Si Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)6/24/2026ODYSOdysight.ai BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/24/2026ODYSOdysight.ai Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeOverweight5/28/2026SENSSenseonics Holdings, Inc. Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/19/2026ODYSOdysight.ai Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/12/2026SENSSenseonics Holdings, Inc. Common Stock HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$18.50 ➝ $14.005/11/2026SENSSenseonics Holdings, Inc. Common Stock Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$9.00 ➝ $8.004/21/2026NAUTNautilus Biotechnology Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 7/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNAUTNautilus BiotechnologyN/AN/AN/AN/A$1.24 per shareN/AODYSOdysight.ai$3.02M24.83N/AN/A$1.55 per share2.88QSIQuantum-Si$1.85M103.79N/AN/A$1.02 per share0.87SENSSenseonics Holdings, Inc. Common Stock$40.71M5.52N/AN/A$1.49 per share3.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNAUTNautilus Biotechnology-$59M-$0.46N/AN/AN/AN/A-35.04%-29.16%7/28/2026 (Estimated)ODYSOdysight.ai-$17.03M-$1.10N/AN/AN/A-1,739.44%-66.30%-58.33%N/AQSIQuantum-Si-$101.34M-$0.51N/AN/AN/A-5,605.88%-47.35%-42.66%8/4/2026 (Estimated)SENSSenseonics Holdings, Inc. Common Stock-$69.11M-$2.00N/AN/AN/A-213.87%-129.97%-67.14%N/ALatest ODYS, NAUT, SENS, and QSI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2026Q2 2026QSIQuantum-Si-$0.13N/AN/AN/A$0.30 millionN/A7/28/2026Q2 2026NAUTNautilus Biotechnology-$0.1350N/AN/AN/A$0.25 millionN/A5/13/2026Q1 2026ODYSOdysight.aiN/A-$0.32N/A-$0.32N/A$0.08 million5/7/2026Q1 2026QSIQuantum-Si-$0.12-$0.10+$0.02-$0.10$0.30 million$0.26 million5/7/2026Q1 2026SENSSenseonics Holdings, Inc. Common Stock-$0.65-$0.71-$0.06-$0.71N/A$11.71 million4/28/2026Q1 2026NAUTNautilus Biotechnology-$0.1450-$0.12+$0.0250-$0.12$0.25 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthNAUTNautilus BiotechnologyN/AN/AN/AN/AN/AODYSOdysight.aiN/AN/AN/AN/AN/AQSIQuantum-SiN/AN/AN/AN/AN/ASENSSenseonics Holdings, Inc. Common StockN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNAUTNautilus BiotechnologyN/A11.8511.85ODYSOdysight.aiN/A7.807.70QSIQuantum-SiN/A12.6012.40SENSSenseonics Holdings, Inc. Common Stock1.053.513.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNAUTNautilus Biotechnology50.71%ODYSOdysight.ai19.67%QSIQuantum-Si39.90%SENSSenseonics Holdings, Inc. Common Stock12.36%Insider OwnershipCompanyInsider OwnershipNAUTNautilus Biotechnology41.10%ODYSOdysight.ai46.90%QSIQuantum-Si22.04%SENSSenseonics Holdings, Inc. Common Stock4.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNAUTNautilus Biotechnology130127.08 million74.85 millionOptionableODYSOdysight.ai4016.81 million8.93 millionN/AQSIQuantum-Si150217.76 million169.77 millionOptionableSENSSenseonics Holdings, Inc. Common Stock9041.80 million39.84 millionN/AODYS, NAUT, SENS, and QSI HeadlinesRecent News About These CompaniesStrength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?June 29, 2026 | zacks.comGMT Capital Corp Lowers Stock Position in Senseonics Holdings, Inc. Common Stock $SENSJune 14, 2026 | marketbeat.comSenseonics Expands Eversense 365 Ecosystem With Welldoc PartnershipJune 11, 2026 | zacks.comReal-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop SystemsJune 6, 2026 | globenewswire.comSenseonics Holdings, Inc. (SENS) Shareholder/Analyst Call TranscriptJune 6, 2026 | seekingalpha.comSenseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026June 1, 2026 | globenewswire.comSenseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder Purchases 22,686 SharesMay 14, 2026 | insidertrades.comSenseonics Holdings, Inc. (NASDAQ:SENS) Q1 2026 Earnings Call TranscriptMay 10, 2026 | insidermonkey.comSenseonics Holdings, Inc. (SENS) Q1 2026 Earnings Call TranscriptMay 8, 2026 | seekingalpha.comSenseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue EstimatesMay 7, 2026 | zacks.comSenseonics Holdings, Inc. Reports First Quarter 2026 Financial ResultsMay 7, 2026 | globenewswire.comSenseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesMay 5, 2026 | markets.businessinsider.comSenseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesMay 4, 2026 | globenewswire.comSenseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 MillionMay 4, 2026 | globenewswire.comSenseonics shares sink Friday: What's driving the move?May 1, 2026 | msn.comSenseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern TimeMay 1, 2026 | globenewswire.comSenseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded WarrantsApril 30, 2026 | globenewswire.comSenseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded WarrantsApril 30, 2026 | globenewswire.comSENS Launches Eversense 365, World's Only One-Year CGM in EuropeApril 27, 2026 | zacks.comSenseonics Announces European Launch of Eversense® 365, The World's First and Only One Year CGM SystemApril 24, 2026 | globenewswire.comSenseonics Reports Strong One-Year Real-World Data for Eversense 365March 17, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird SatellitesBy Jessica Mitacek | June 16, 20263 Stocks That Could Benefit as the Robotaxi Race Heats UpBy Nathan Reiff | June 27, 2026Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term InvestorsBy Thomas Hughes | July 6, 2026Ouster Is Breaking Out as a Physical AI Leader: Here's What's Driving the MoveBy Ryan Hasson | July 1, 2026ODYS, NAUT, SENS, and QSI Company DescriptionsNautilus Biotechnology NASDAQ:NAUT$1.89 0.00 (0.00%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$1.90 +0.02 (+0.79%) As of 08:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.Odysight.ai NASDAQ:ODYS$4.46 0.00 (0.00%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$4.46 +0.00 (+0.11%) As of 07:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Odysight.ai, Inc. engages in the development and manufacture of customized visual solutions for organizations across a variety of industries in the form of micro cameras and supplementary technologies. Its devices can used across the medical, aerospace, industrial, research, and defense industries. The company was founded on March 22, 2013 and is headquartered in Omer, Israel.Quantum-Si NASDAQ:QSI$0.88 0.00 (0.00%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$0.88 0.00 (-0.19%) As of 07:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.Senseonics Holdings, Inc. Common Stock NASDAQ:SENS$5.38 0.00 (0.00%) Closing price 07/10/2026 04:00 PM EasternExtended Trading$5.30 -0.09 (-1.58%) As of 07:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/06 - 07/10 Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing Why WD-40 Is Proving Great Businesses Never Go Out of Style Rocket Lab’s Stock Drop Comes With a Bullish Twist Why "Big Short" Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs Power Struggle: Wolfspeed Sues Navitas Over AI Chips Pushing the Edge: Super Micro Computer Reboots the AI Landscape Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
